anti depdc1b Search Results


pole2 polyclonal antibody  (Bioss)
93
Bioss pole2 polyclonal antibody
Pole2 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+depdc1b/custom%40bs-14356r%4010398932?v=Bioss
Average 93 stars, based on 1 article reviews
pole2 polyclonal antibody - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
membranous lihc cells  (Atlas Antibodies)
93
Atlas Antibodies membranous lihc cells
FIGURE 1 | DEPDC1B expression in <t>LIHC</t> tissues using online databases. (A) Expression of DEPDC1B (normal compared with cancer tissue) were analyzed using Oncomine database. The table shows the number of significant analyses across the whole Oncomine database (715 datasets and 86.733 samples). DEPDC1B shows high/low expression ratio of 31/1 from 32 analyses. The cell color is determined by the best gene rank percentile for the analyses within the cell. The number in each cell represents the number of analyses that meet the threshold within those analysis and cancer types. The gene rank was analyzed by percentile of target gene in the top of all genes measured in each research. (B) UALCAN database. The number of patients in normal and primary tumor groups was 50 and 371, respectively. p 1.11e- 16. (C) TCGA database using R script. Normal (n 50), Tumor (n 374). p 4.042e-21. (D) DEPDC1B expression in a paired comparison of LIHC and their adjacent tissues. Data were extracted from the TCGA database. n 50. p 2.122e-11.
Membranous Lihc Cells, supplied by Atlas Antibodies, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+depdc1b/pm35095994-158-6-12?v=Atlas+Antibodies
Average 93 stars, based on 1 article reviews
membranous lihc cells - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
rabbit anti depdc1b antibody  (GenScript corporation)
90
GenScript corporation rabbit anti depdc1b antibody
FIGURE 1 | DEPDC1B expression in <t>LIHC</t> tissues using online databases. (A) Expression of DEPDC1B (normal compared with cancer tissue) were analyzed using Oncomine database. The table shows the number of significant analyses across the whole Oncomine database (715 datasets and 86.733 samples). DEPDC1B shows high/low expression ratio of 31/1 from 32 analyses. The cell color is determined by the best gene rank percentile for the analyses within the cell. The number in each cell represents the number of analyses that meet the threshold within those analysis and cancer types. The gene rank was analyzed by percentile of target gene in the top of all genes measured in each research. (B) UALCAN database. The number of patients in normal and primary tumor groups was 50 and 371, respectively. p 1.11e- 16. (C) TCGA database using R script. Normal (n 50), Tumor (n 374). p 4.042e-21. (D) DEPDC1B expression in a paired comparison of LIHC and their adjacent tissues. Data were extracted from the TCGA database. n 50. p 2.122e-11.
Rabbit Anti Depdc1b Antibody, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+depdc1b/pmc08981904-199-1-6?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
rabbit anti depdc1b antibody - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
anti-depdc1b-brcc3 polyclonal antibody  (TargetMol)
N/A
   Buy from Supplier
rabbit anti-human depdc1b polyclonal antibody  (Cusabio)
N/A
Rabbit anti-Human DEPDC1B Polyclonal Antibody
   Buy from Supplier
anti-depdc1b antibody  (Boster Bio)
N/A
Boster Bio Anti-DEPDC1B Antibody (Catalog # A11735). Tested in ELISA, WB, IHC-P applications. This antibody reacts with Human.
   Buy from Supplier
anti-depdc1b (aa 461-491) polyclonal antibody  (Creative BioMart)
N/A
GTPase activator activity. biological process: intracellular signaling cascadeStore at 4°C (up to 6 months). For long term storage store at -20°Chttp://www.creative-diagnostics.com/Anti-DEPDC1B-PAb-211112-147.htm
   Buy from Supplier

Image Search Results


FIGURE 1 | DEPDC1B expression in LIHC tissues using online databases. (A) Expression of DEPDC1B (normal compared with cancer tissue) were analyzed using Oncomine database. The table shows the number of significant analyses across the whole Oncomine database (715 datasets and 86.733 samples). DEPDC1B shows high/low expression ratio of 31/1 from 32 analyses. The cell color is determined by the best gene rank percentile for the analyses within the cell. The number in each cell represents the number of analyses that meet the threshold within those analysis and cancer types. The gene rank was analyzed by percentile of target gene in the top of all genes measured in each research. (B) UALCAN database. The number of patients in normal and primary tumor groups was 50 and 371, respectively. p 1.11e- 16. (C) TCGA database using R script. Normal (n 50), Tumor (n 374). p 4.042e-21. (D) DEPDC1B expression in a paired comparison of LIHC and their adjacent tissues. Data were extracted from the TCGA database. n 50. p 2.122e-11.

Journal: Frontiers in genetics

Article Title: Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma.

doi: 10.3389/fgene.2021.681809

Figure Lengend Snippet: FIGURE 1 | DEPDC1B expression in LIHC tissues using online databases. (A) Expression of DEPDC1B (normal compared with cancer tissue) were analyzed using Oncomine database. The table shows the number of significant analyses across the whole Oncomine database (715 datasets and 86.733 samples). DEPDC1B shows high/low expression ratio of 31/1 from 32 analyses. The cell color is determined by the best gene rank percentile for the analyses within the cell. The number in each cell represents the number of analyses that meet the threshold within those analysis and cancer types. The gene rank was analyzed by percentile of target gene in the top of all genes measured in each research. (B) UALCAN database. The number of patients in normal and primary tumor groups was 50 and 371, respectively. p 1.11e- 16. (C) TCGA database using R script. Normal (n 50), Tumor (n 374). p 4.042e-21. (D) DEPDC1B expression in a paired comparison of LIHC and their adjacent tissues. Data were extracted from the TCGA database. n 50. p 2.122e-11.

Article Snippet: DEPDC1B was mainly stained in the cytoplasmic/membranous LIHC cells using HPA072558 antibody (Atlas Antibodies Sigma-Aldrich).

Techniques: Expressing, Comparison

FIGURE 2 | Prognostic potential of DEPDC1B in LIHC. Four online tools were used to evaluate the relationships between DEPDC1B expression and patient survival. (A) OS in UALCAN database, the samples were divided into high DEPDC1B expression (n 88) and low/medium DEPDC1B expression (n 277) groups according to the median of DEPDC1B expression. p 0.0045 (B) OS in GEPIA database. The samples were divided into high DEPDC1B expression (n 181) and low DEPDC1B expression (n 181) groups according to the median of DEPDC1B expression. p 0.0039 (C) OS in Kaplan-Meier Plotter database. The number of patients in high and low groups was 252, 112, respectively. p 0.00033 (D) OS in TCGA database, p 0.005. The samples were divided into high DEPDC1B expression (n 260) and low DEPDC1B expression (n 110) groups according to the median of DEPDC1B expression. p 0.005. OS: overall survival.

Journal: Frontiers in genetics

Article Title: Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma.

doi: 10.3389/fgene.2021.681809

Figure Lengend Snippet: FIGURE 2 | Prognostic potential of DEPDC1B in LIHC. Four online tools were used to evaluate the relationships between DEPDC1B expression and patient survival. (A) OS in UALCAN database, the samples were divided into high DEPDC1B expression (n 88) and low/medium DEPDC1B expression (n 277) groups according to the median of DEPDC1B expression. p 0.0045 (B) OS in GEPIA database. The samples were divided into high DEPDC1B expression (n 181) and low DEPDC1B expression (n 181) groups according to the median of DEPDC1B expression. p 0.0039 (C) OS in Kaplan-Meier Plotter database. The number of patients in high and low groups was 252, 112, respectively. p 0.00033 (D) OS in TCGA database, p 0.005. The samples were divided into high DEPDC1B expression (n 260) and low DEPDC1B expression (n 110) groups according to the median of DEPDC1B expression. p 0.005. OS: overall survival.

Article Snippet: DEPDC1B was mainly stained in the cytoplasmic/membranous LIHC cells using HPA072558 antibody (Atlas Antibodies Sigma-Aldrich).

Techniques: Expressing

FIGURE 3 | DEPDC1B is an independent risk factor for OS among LIHC patients using multivariate Cox analysis. **p 0.007.

Journal: Frontiers in genetics

Article Title: Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma.

doi: 10.3389/fgene.2021.681809

Figure Lengend Snippet: FIGURE 3 | DEPDC1B is an independent risk factor for OS among LIHC patients using multivariate Cox analysis. **p 0.007.

Article Snippet: DEPDC1B was mainly stained in the cytoplasmic/membranous LIHC cells using HPA072558 antibody (Atlas Antibodies Sigma-Aldrich).

Techniques:

FIGURE 4 | Diagnostical potential of DEPDC1B expression in LIHC. Association between DEPDC1B expression and clinical characters: (A) cancer stage. Normal vs Stage 1, p 1.62e-12; Normal vs. Stage 2, p 3.44e-06; Normal vs. Stage 3, p 2.59e-07; Stage 1 vs. Stage 3, p 2.15e-03. (B) patient’s age. Normal vs. Age (21–40 Years), p 9.70e-05; Normal vs. Age (41–60 Years), p 6.92e-11; Normal vs. Age (61–80 Years), p 6.81e-10, Normal vs. Age (81–100 Years), p r0.046. (C) tumor grade. Normal vs Grade 1, p 4.80e-02; Normal vs Grade 2, p 2.85e-12; Normal vs Grade 3, p 8.09e-12; Normal vs. Grade 4, p 1.30e-03. Grade 2 vs. Grade 3, p 3.30e-03. (D) LIHC nodal metastasis status. Normal vs. N0, p < 1E-12. (E) TP53 mutation status. Normal vs. TP53-Mutant, p < 1E-12; Normal vs. TP53- NonMutant, p 1.99e-11; TP53-Mutant vs. TP53-NonMutant, p 1.94e-03. (F) Diagnosis value of DEPDC1B using ROC analysis. AUC: area under ROC curve. Student’s t test was used to generate a p-value. *p < 0.05, **p < 0.01, ***p < 0.001.

Journal: Frontiers in genetics

Article Title: Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma.

doi: 10.3389/fgene.2021.681809

Figure Lengend Snippet: FIGURE 4 | Diagnostical potential of DEPDC1B expression in LIHC. Association between DEPDC1B expression and clinical characters: (A) cancer stage. Normal vs Stage 1, p 1.62e-12; Normal vs. Stage 2, p 3.44e-06; Normal vs. Stage 3, p 2.59e-07; Stage 1 vs. Stage 3, p 2.15e-03. (B) patient’s age. Normal vs. Age (21–40 Years), p 9.70e-05; Normal vs. Age (41–60 Years), p 6.92e-11; Normal vs. Age (61–80 Years), p 6.81e-10, Normal vs. Age (81–100 Years), p r0.046. (C) tumor grade. Normal vs Grade 1, p 4.80e-02; Normal vs Grade 2, p 2.85e-12; Normal vs Grade 3, p 8.09e-12; Normal vs. Grade 4, p 1.30e-03. Grade 2 vs. Grade 3, p 3.30e-03. (D) LIHC nodal metastasis status. Normal vs. N0, p < 1E-12. (E) TP53 mutation status. Normal vs. TP53-Mutant, p < 1E-12; Normal vs. TP53- NonMutant, p 1.99e-11; TP53-Mutant vs. TP53-NonMutant, p 1.94e-03. (F) Diagnosis value of DEPDC1B using ROC analysis. AUC: area under ROC curve. Student’s t test was used to generate a p-value. *p < 0.05, **p < 0.01, ***p < 0.001.

Article Snippet: DEPDC1B was mainly stained in the cytoplasmic/membranous LIHC cells using HPA072558 antibody (Atlas Antibodies Sigma-Aldrich).

Techniques: Expressing, Mutagenesis, Biomarker Discovery

FIGURE 6 | immunohistochemistry of DEPDC1B in various types of cancer (A) and LIHC tissues (B–E) using HPA072558 antibody. (A) Strong cytoplasmic positivity was displayed in several hepatocellular carcinomas and single cases of carcinoma and urothelial cancer. Several endometrial cancers and a few other cancer tissues showed moderate immunoreactivity. The remaining cancer tissues were weakly stained or negative. Tumor cells staining: high expression (B,C) and medium expression (D,E); (B)Patient id: 3,477, male, age 67; (C): Patient id: 5,032, female, age 58; (D) Patient id: 3,196, male, age 65; (E) Patient id: 4,823, female, age 25. DEPDC1B was mainly stained in the cytoplasmic/membranous LIHC cells using HPA072558 antibody (Atlas Antibodies Sigma-Aldrich).

Journal: Frontiers in genetics

Article Title: Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma.

doi: 10.3389/fgene.2021.681809

Figure Lengend Snippet: FIGURE 6 | immunohistochemistry of DEPDC1B in various types of cancer (A) and LIHC tissues (B–E) using HPA072558 antibody. (A) Strong cytoplasmic positivity was displayed in several hepatocellular carcinomas and single cases of carcinoma and urothelial cancer. Several endometrial cancers and a few other cancer tissues showed moderate immunoreactivity. The remaining cancer tissues were weakly stained or negative. Tumor cells staining: high expression (B,C) and medium expression (D,E); (B)Patient id: 3,477, male, age 67; (C): Patient id: 5,032, female, age 58; (D) Patient id: 3,196, male, age 65; (E) Patient id: 4,823, female, age 25. DEPDC1B was mainly stained in the cytoplasmic/membranous LIHC cells using HPA072558 antibody (Atlas Antibodies Sigma-Aldrich).

Article Snippet: DEPDC1B was mainly stained in the cytoplasmic/membranous LIHC cells using HPA072558 antibody (Atlas Antibodies Sigma-Aldrich).

Techniques: Immunohistochemistry, Staining, Expressing

FIGURE 7 | DEPDC1B mRNA expression is frequently upregulated in LIHC tissues. T: LIHC tissues; N: noncancerous tissues. The results were shown with Mean ± SD. N 5, **p < 0.01.

Journal: Frontiers in genetics

Article Title: Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma.

doi: 10.3389/fgene.2021.681809

Figure Lengend Snippet: FIGURE 7 | DEPDC1B mRNA expression is frequently upregulated in LIHC tissues. T: LIHC tissues; N: noncancerous tissues. The results were shown with Mean ± SD. N 5, **p < 0.01.

Article Snippet: DEPDC1B was mainly stained in the cytoplasmic/membranous LIHC cells using HPA072558 antibody (Atlas Antibodies Sigma-Aldrich).

Techniques: Expressing